Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 82 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

34%

28 trials in Phase 3/4

Results Transparency

10%

2 of 21 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

67Total
Not Applicable (26)
P 1 (1)
P 2 (12)
P 3 (15)
P 4 (13)

Trial Status

Recruiting30
Completed21
Not Yet Recruiting15
Unknown14
Enrolling By Invitation1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 21 completed trials

Clinical Trials (82)

Showing 20 of 20 trials
NCT07324837Phase 3RecruitingPrimary

Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

NCT07731282Not ApplicableCompletedPrimary

Benson Relaxation for Anxiety, Depression, and Insomnia After Stroke

NCT07668323Phase 3Recruiting

Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion

NCT05051397Phase 2RecruitingPrimary

CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke

NCT07785492Not ApplicableRecruitingPrimary

Artificial Intelligence Support for Stroke

NCT07763405Phase 4Not Yet RecruitingPrimary

Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke

NCT07760922Phase 4Not Yet RecruitingPrimary

Tirofiban Combined With Aspirin in Moderate Ischemic Stroke

NCT07386262Not ApplicableNot Yet Recruiting

A Trial of Adacolumn on Cerebral Edema After Anterior Circulation Ischemic Stroke

NCT06442631Not ApplicableNot Yet Recruiting

MyStroke for Stroke Survivors and Caregivers

NCT05487417Phase 4CompletedPrimary

Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy

NCT07721129Phase 4Not Yet RecruitingPrimary

TeleStroke-Guided Thrombolysis for Acute Ischemic Stroke in Oman

NCT06352619Not ApplicableRecruitingPrimary

Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial

NCT07690020Not ApplicableNot Yet RecruitingPrimary

Clinical Efficacy and Mechanism Research of Getong Tongluo Capsule in Ischemic Stroke

NCT07687706Phase 3Recruiting

Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)

NCT06094478Not ApplicableRecruiting

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

NCT05892510Phase 2RecruitingPrimary

Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

NCT05600374Not ApplicableRecruitingPrimary

Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke

NCT07091994Phase 4Not Yet RecruitingPrimary

A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy

NCT07531394Phase 3Not Yet RecruitingPrimary

Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke

NCT06018181CompletedPrimary

Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

Scroll to load more

Research Network

Activity Timeline